Positive Half-Yearly Results for Bastide

Bastide Group has unveiled its 2024-2025 half-year results, marking a significant improvement in its operating margin. Revenue increased by 4.0% to €275.5 million, driven by organic growth of 8.5%. Technical activities, particularly in Respiratory and Diabetes, drove this growth, with a like-for-like increase of 12.1% for Respiratory Assistance.

The current operating margin stood at a record 9.1%, thanks to the consolidation of home healthcare services and optimized management. Although overall net income decreased slightly to €2.2 million, free operating cash flow increased significantly to €9.4 million.

Financial leverage also shows improvement, with a net financial debt/EBITDA ratio of 3.48x. Bastide projects an operating margin above 9.1% for the full year, despite upcoming price adjustments.